These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 20515556)

  • 21. Multi-slice CT contrast-enhanced presentations of advanced gastric cancer: associations with histo-differentiation and expression of p53 and P-glycoprotein.
    Yin XD; Zhao JH; Zhang L; Wang LP; Lu LQ; Wang LW; Xie GH; Wu QZ; Wang SZ; Gu JP
    Chin Med J (Engl); 2008 Dec; 121(24):2487-91. PubMed ID: 19187583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and prognostic significance of CEACAM6, ITGB1, and CYR61 in peripheral blood of patients with gastric cancer.
    Zhao ZS; Li L; Wang HJ; Wang YY
    J Surg Oncol; 2011 Oct; 104(5):525-9. PubMed ID: 21618249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Impact of clinicopathological features and extent of lymph node dissection on the prognosis in early gastric cancer patients].
    Wu H; Wang L; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Zhan WH
    Zhonghua Zhong Liu Za Zhi; 2013 Jul; 35(7):509-13. PubMed ID: 24257302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
    Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
    Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic role of serum p53 antibodies in lung cancer.
    Mattioni M; Soddu S; Prodosmo A; Visca P; Conti S; Alessandrini G; Facciolo F; Strigari L
    BMC Cancer; 2015 Mar; 15():148. PubMed ID: 25884692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The predictors of response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer.
    Qu J; Qu X
    Cancer Biomark; 2016 Jun; 17(1):49-54. PubMed ID: 27314292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship between promoter methylation of Syk and Runx3 genes and postoperative recurrence and metastasis in gastric carcinoma].
    Hong H; Zhou K; Fu P; Huang Q; Wang J; Yuan X; Li J
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):341-5. PubMed ID: 25030588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.
    Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH
    Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Significance of Carcinoembryonic Antigen Staining in Cancer Tissues of Gastric Cancer Patients.
    Wang W; Seeruttun SR; Fang C; Chen J; Li Y; Liu Z; Zhan Y; Li W; Chen Y; Sun X; Li Y; Xu D; Guan Y; Zhou Z
    Ann Surg Oncol; 2016 Apr; 23(4):1244-51. PubMed ID: 26620645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of c-erbB-2 oncoprotein expression in tissue and serum of patients with stomach cancer.
    Chariyalertsak S; Sugano K; Ohkura H; Mori Y
    Tumour Biol; 1994; 15(5):294-303. PubMed ID: 7991990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term outcome and analysis of prognostic factors in 114 cases of postoperative stage III gastric cancer].
    Zhang Y; Ma LW
    Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):863-6. PubMed ID: 24447487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer.
    Kim BS; Oh ST; Yook JH; Kim BS
    Surgery; 2014 Jun; 155(6):1030-5. PubMed ID: 24792508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 and P-glycoprotein expression are significant prognostic markers in advanced head and neck cancer treated with chemo/radiotherapy.
    Warnakulasuriya S; Jia C; Johnson N; Houghton J
    J Pathol; 2000 May; 191(1):33-8. PubMed ID: 10767716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of serum p53 antibodies is associated with decreased in vitro chemosensitivity in patients with esophageal cancer.
    Shimada H; Okazumi S; Takeda A; Nabeya Y; Matsubara H; Funami Y; Hayashi H; Gunji Y; Suzuki T; Ochiai T
    Surg Today; 2001; 31(7):591-6. PubMed ID: 11495153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study on tissue polypeptide antigen (TPA) in gastric cancer].
    Kanauchi M; Sawai F; Hirayama T; Yumura F; Kanauchi K; Hamaguchi T; Hara Y; Yoshimura K; Nishiura K; Dohi K
    Gan No Rinsho; 1985 Sep; 31(11):1367-71. PubMed ID: 2999464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy.
    Sun Z; Zhang N
    World J Surg Oncol; 2014 Dec; 12():397. PubMed ID: 25543664
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer.
    de Cuba EM; de Hingh IH; Sluiter NR; Kwakman R; Coupé VM; Beliën JA; Verwaal VJ; Meijerink WJ; Delis-van Diemen PM; Bonjer HJ; Meijer GA; Te Velde EA
    Ann Surg Oncol; 2016 May; 23(5):1601-8. PubMed ID: 26727921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of expression of Kit67, p53, TopoIIa and GSTP1 for curatively resected advanced gastric cancer patients receiving adjuvant paclitaxel plus capecitabine chemotherapy.
    Zha Y; Cun Y; Zhang Q; Li Y; Tan J
    Hepatogastroenterology; 2012; 59(117):1327-32. PubMed ID: 22534478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Signet Ring Cells and Efficacy of First-line Chemotherapy in Advanced Gastric or Oesogastric Junction Adenocarcinoma.
    Lemoine N; Adenis A; Bouche O; Duhamel A; Heurgue A; Leteurtre E; Amela E; Salleron J; Hebbar M
    Anticancer Res; 2016 Oct; 36(10):5543-5549. PubMed ID: 27798928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.